Eric R. Siegel

High Impact

Research Associate

UAMS

Last publication 2026 Last refreshed 2026-05-16

postdoc

siegelericr@uams.edu

50 h-index 417 pubs 9,779 cited

Research Areas

Links

ORCID Google Scholar Research Group

OverviewAI-generated summary

Eric R. Siegel's research focuses on cancer treatment and pharmacology, with a particular emphasis on immunotherapy and novel therapeutic agents. He has investigated the efficacy of pembrolizumab in endometrial cancers, including those with Lynch-like and microsatellite instability characteristics. His work also explores the potential of bispecific CAR-T cells for controlling multiple myeloma growth and the tolerability of trastuzumab in advanced uterine serous carcinomas.

Further research interests include understanding immune microenvironment alterations in multiple myeloma and its precursor stages, and the impact of dietary interventions, such as methionine restriction, on the response to immune checkpoint inhibitors in colorectal cancer models. Siegel also examines the preliminary results of trials involving sacituzumab govitecan-hziy for recurrent endometrial carcinoma. His research network includes collaborators such as Simon C. Mears, Guido Tricot, Sharmilan Thanendrarajan, and John D. Shaughnessy, all from the University of Arkansas for Medical Sciences, with whom he has co-authored multiple publications.

Siegel's scholarship metrics include an h-index of 50, with over 418 publications and 9,685 citations. He is recognized as a highly cited researcher and leads a research group at the University of Arkansas for Medical Sciences.

Metrics

h-index: 50
Publications: 417
Citations: 9,779

Selected Publications

Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols (2025)

3 citations DOI OpenAlex
A phase 2 trial of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability (NCT02899793): Updated survival and response analyses (2025)

2 citations DOI OpenAlex
Does Patient Health Literacy Affect Patient Reported Outcome Measure Completion Method in Orthopaedic Patients? (2025)

4 citations DOI OpenAlex
A customized bed based stand alone array of optically pumped magnetometers for fetal magnetocardiography measurements (2025)

6 citations DOI OpenAlex
Prior exposure to belantamab mafodotin influences outcomes with idecabtagene vicleucel in patients with multiple myeloma (2025)

4 citations DOI OpenAlex
N-acetylcysteine (NAC) supplementation improves dyspnea and may normalize von Willebrand plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID (2025)

3 citations DOI OpenAlex
Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma (2024)

5 citations DOI OpenAlex
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages (2024)

24 citations DOI OpenAlex
Does Body Mass Index Affect the Success of Two-Stage Management of Periprosthetic Joint Infection? (2024)

2 citations DOI OpenAlex
Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections (2024)

3 citations DOI OpenAlex
Pediatric Off-Road Vehicle Injuries (2024)

2 citations DOI OpenAlex
Correlating maternal and cord-blood inflammatory markers and BDNF with human fetal brain activity recorded by magnetoencephalography: An exploratory study (2024)

3 citations DOI OpenAlex
Fetal magnetocardiographic recordings with a prototype bed-based array system of optically-pumped magnetometers (2024)

8 citations DOI OpenAlex
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix (2024)

14 citations DOI OpenAlex
Successful Transition to Same Calendar Day Discharge in Total Joint Arthroplasty at an Academic Center (2024)

5 citations DOI OpenAlex